IL18 and familial pancreatic carcinoma: Combined inhibition of IL-18 and PD-L1/PD-1 pathways with synthetic inhibitors reduces PDAC growth and metastasis formation in orthotopic animal models, reinforcing the in vivo relevance of the crosstalk between Breg and cancer cells for the progression of pancreatic cancer (130).